Indra Nooyi was Chairman of PepsiCo’s Board of Directors. She has served in this role since 2007. Previously, she served as Chief Executive Officer from 2006 to October 2, 2018. As CEO, Mrs. Nooyi was the chief architect of Performance with Purpose, PepsiCo’s pledge to do what’s right for the business by being responsive to the needs of the world around us. As part of Performance with Purpose, PepsiCo is focusing on delivering sustained growth by making more nutritious products, limiting our environmental footprint and protecting the planet, and empowering our associates and people in the communities we serve.She directed the company’s global strategy for more than a decade and led its restructuring, including the divestiture of its restaurants into the successful YUM! Brands, Inc. She also led the acquisition of Tropicana and the merger with Quaker Oats that brought the vital Quaker and Gatorade businesses to PepsiCo, the merger with PepsiCo’s anchor bottlers, and the acquisition of Wimm-Bill-Dann, the largest international acquisition in PepsiCo’s history.Prior to becoming CEO, Mrs. Nooyi served as President and Chief Financial Officer beginning in 2001, when she was also named to PepsiCo’s Board of Directors. In this position, she was responsible for PepsiCo’s corporate functions, including finance, strategy, business process optimization, corporate platforms and innovation, procurement, investor relations and information technology.View the profile
Mehmood Khan, M.D., is Chief Executive Officer and Board Member of Life Biosciences Inc. He joined the company in April 2019. Founded in 2017 and headquartered in Boston, Massachusetts, Life Biosciences is a biotechnology company developing therapies for age-related diseases by focusing on the biology of aging. Its ultimate goal is to significantly extend healthy human lifespan. In his role as CEO, Dr. Khan provides strategic direction and operational oversight. His vision of a more efficient and effective drug development pathway will drive innovation in the science and technology Life Biosciences advances.Dr. Khan previously served as Vice Chairman and Chief Scientific Officer of Global Research and Development at PepsiCo, a Fortune 50 company with upwards of 250,000 employees across 22 brands. At PepsiCo, Dr. Khan played a pivotal role in their global R&D efforts to create breakthrough innovations in food, beverages and nutrition, including the incorporation of healthier and more nutritions offerings across its portfolio. Dr. Khan also oversaw PepsiCo’s global sustainability of the world we share. Prior to joining PepsiCo, Dr.Khan served as president of Global R&D Center at Takeda Pharmaceuticals, leading the global efforts one of the largest pharmaceutical companies in the world by revenue.View the profile
About the talk
Buy this talk
Buy this video
With ConferenceCast.tv, you get access to our library of the world's best conference talks.